Nachrichten zur ABBVIE Aktie

This Vanguard ETF Has 23% of Its Portfolio Invested in Tech Stocks, but It Can Still Help You Generate Decades of Passive Income

The technology sector has crushed the S&P 500 over the past three, five, and 10 years as leading tech stocks…

The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio

Visa, AbbVie, Analog Devices and Precipio are included in this Analyst Blog.…

AbbVie Inc. (ABBV) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)

…

Top Research Reports for Visa, AbbVie & Analog Devices

Todays Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AbbVie Inc. (ABBV) and Analog…

2 Brilliant Dividend Growth Stocks That Can Supercharge Your Portfolio

Dividend growth investing is a powerful strategy for building lasting wealth. Companies that consistently raise their dividends tend to possess…

3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees

If youre a retiree looking for dependable and reliable dividend income, there are many quality stocks out there that can…

AbbVie Has Immense Cash Flow Potential

…

AbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock?

Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks…

3 High-Yield Dividend Stocks to Buy in 2025

High-yield dividend stocks may not appeal to some investors. However, if youre among those investors looking for income, stocks that…

AbbVie’s SKYRIZI[®] (risankizumab) Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative Colitis

PRESS RELEASE – For UK consumer health, medical and trade media only · [ ]Risankizumab will be available on the…

AbbVie Takes $3.5B Impairment Charge for Failed Schizophrenia Drug

…

AbbVie Aktie: Paukenschlag

Kulmbach (www.aktiencheck.de) - AbbVie-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" in einer aktuellen Aktienanalyse nimmt die Aktie von…

AbbVie: Milliarden-Abschreibung nach Übernahme-Flop

Paukenschlag beim US-Pharma-Riesen AbbVie: Der Humira-Entwickler muss eine milliardenschwere Abschreibung vornehmen. Das geht aus einem aktuellen Filing an die US-Börsenaufsicht…

AbbVie: Milliarden-Abschreibung nach Übernahme-Flop

Paukenschlag beim US-Pharma-Riesen AbbVie: Der Humira-Entwickler muss eine milliardenschwere Abschreibung vornehmen. Das geht aus einem aktuellen Filing an die US-Börsenaufsicht…

AbbVie Aktie: Gut positioniert für langfristiges Wachstum

Charlotte, NC (www.aktiencheck.de) - AbbVie-Aktienanalyse von Truist: Analyst Srikripa Devarakonda hat das Kursziel für die Aktie von AbbVie Inc. (ISIN: US00287Y1091,…

AbbVies Stock Is Unfairly Cheap

…

AbbVie cuts 2024 profit forecast on acquisition expenses By Reuters

AbbVie cuts 2024 profit forecast on acquisition expenses…

AbbVie cuts 2024 profit forecast on acquisition expenses

AbbVie lowered its 2024 adjusted profit forecast on Monday as the drugmaker incurred $1.6 billion in acquisition expenses related to…

25 Top Dividend Stocks to Buy and Hold in 2025

As long as investors seek income, dividends never go out of style. And there will always be investors who want…

2 No-Brainer Dividend Stocks to Buy With $250 in 2025

When it comes to dividend investing, there are two basic paths you can take. You could seek out businesses that…

3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

If youre worried about having enough passive income to maintain your lifestyle during retirement, youre not alone. Having to spend…

The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer

Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer are included in this Analyst Blog.…

$2.5+ Bn Body Contouring Treatments Markets - Global Analysis and Forecasts to 2029 with AbbVie, Inmode), Bausch Health, Cynosure Lutronic, and Sisram Medical Leading

Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Body Contouring Treatments Market by Product (System (CT, MRI, Angiography,…

Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for AbbVie (ABBV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…

3 High-Yield Dividend ETFs to Buy to Generate Passive Income

Investors of all types can benefit from the power of dividend stocks. Although dividends are usually sought by those in…

The Smartest Dividend Stocks to Buy With $1,000 Right Now

If youre looking for attractive dividend-paying stocks, thats a smart move. If youre not, perhaps reconsider -- because: Healthy and growing…

1 Vanguard Index Fund Could Turn $375 Per Month Into a $569,400 Portfolio That Pays $17,200 in Annual Dividend Income

The median weekly income for U.S. workers was $1,165 in the third quarter, which is roughly $60,500 per year, according…

Is AbbVie Stock a Buy?

With its shares offering a total return of nearly 49% over the last three years, trumping the markets return of…

2 Excellent Dividend Stocks to Buy on the Dip

AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN) have a lot in common. They are both leading drugmakers and have strong…

2 Unstoppable Dividend Stocks to Buy If Theres a Stock Market Sell-Off

Stock market investors have plenty of reasons to celebrate as 2024 comes to a close. The S&P 500 index set…

PTA-News: Small- & MicroCap Investment: Mehr Potenzial als Eli Lilly oder AbbVie? Analysten mit Top-Prognosen für NurExone

DJ PTA-News: Small- & MicroCap Investment: Mehr Potenzial als Eli Lilly oder AbbVie? Analysten mit Top-Prognosen für NurExone Unternehmensmitteilung für…

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

Santa Claus will soon be on his way delivering presents to kids around the world. But could the jolly gift-giver…

2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond

What will be the hottest investing trend on Wall Street next year? Maybe artificial intelligence will keep up its momentum,…

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could…

4 Big Drug Stocks That May Continue to Outperform in 2025

Gilead, Eli Lilly, Vertex Pharmaceuticals and AbbVie have outperformed the industry this year and are likely to see continued momentum…

AbbVie to acquire Roche spinout Nimble for $200M upfront

…

1 Magnificent S&P 500 Dividend Stock Down 14% to Buy and Hold Forever

This will go down in history as an incredible year for stocks. The S&P 500 hit a new all-time high…

AbbVies Recently Acquired Parkinsons Drug Meets Third Study Goal

Data from a late-stage study shows that treatment with flexible doses of ABBVs tavapadon reduced the burden of Parkinsons disease.…

Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences

Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), AbbVie Inc. (ABBV)…

While This High-Yield Dividend ETF Holds 75 Stocks, Its Top 2 Comprise 16.5% of Its Total Holdings

iShares Core High Dividend ETF (NYSEMKT: HDV) is a popular exchange-traded fund (ETF) among those seeking to generate passive income.…

2 Simple ETFs to Buy With $1,000 and Hold for a Lifetime

One of the best ways to grow your wealth is to invest in exchange-traded funds (ETFs). These products offer investors…

AbbVie Inc. (ABBV) Citis 2024 Global Healthcare Conference (Transcript)

…

3 High-Yield Dividend Growth Stocks to Buy in December and Hold for a Decade or Longer

Its been a great couple of years for the stock market. From the end of 2022 through Nov. 29, the…

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later

You dont have to be an income investor to like dividends. Many billionaires who definitely dont need income still have…

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

Generating long-term passive income is easier than you might think. Here are three stocks to buy now and hold…

3 Unstoppable ETFs to Buy Right Now

Exchange-traded funds (ETF) have revolutionized investing by offering investors an efficient way to build wealth through diversified portfolios. ETFs combine…

AbbVie Aktie: Skyrizi als zentraler Wachstumstreiber

Boston, MA (www.aktiencheck.de) - AbbVie-Aktienanalyse von Leerink Partners: Leerink Partners hat die Aktie von AbbVie Inc. (ISIN: US00287Y1091, WKN: A1J84E, Ticker-Symbol:…

2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical…

Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead

…